Human adipose-derived mesenchymal stem cells utilized to treat cartilage defects in Phase IIa trial

Written by Regenerative Medicine

In this research article, human adipose-derived mesenchymal progenitor cells were investigated both for safety and efficacy in treating cartilage defects in 30 patients. The Regenerative Medicine journal has published a new Phase II clinical trial seeking to assess the safety and efficacy of utilizing human mesenchymal stem cells in the repair of cartilage defects in thirty patients. By treating patients with the mesenchymal progenitor cells, commonly understood to be able to undergo differentiation into chondrocytes and osteoblasts, alongside a microfracture and hyaluronic acid approach, the researchers were investigating the ability to relieve joint pain in patients. Aim: The study aimed...

To view this content, please register now for access

It's completely free